MPM
EBS icon

Meritage Portfolio Management’s Emergent Biosolutions EBS Stock Holding History

Meritage Portfolio Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-100,004
Closed -$5.93M – 187
2018
Q4 		$5.93M Sell
100,004
-1,699
-2% -$110K 0.68% 36
2018
Q3 		$6.7M Sell
101,703
-1,123
-1% -$65.5K 0.61% 46
2018
Q2 		$5.19M Buy
+102,826
New +$5.36M 0.51% 83

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Meritage Portfolio Management's EBS Position: Q1 2019 in Review

Meritage Portfolio Management sold out of Emergent Biosolutions (EBS) in Q1 2019, closing a stake of 100,004 shares — an estimated $5.93M sold.

Meritage Portfolio Management first reported a position in EBS in Q2 2018 and held it in 3 quarters. The position peaked at $6.7M in Q3 2018. 272 funds tracked by Wall St. Rank hold EBS as of Q1 2019.

  • Meritage Portfolio Management reported no remaining Emergent Biosolutions position as of Q1 2019 after selling out during the quarter.
  • Meritage Portfolio Management sold 100,004 Emergent Biosolutions shares in Q1 2019, an estimated $5.93M.
  • Meritage Portfolio Management first reported a position in Emergent Biosolutions in Q2 2018 and held it in 3 quarters.
  • Meritage Portfolio Management's Emergent Biosolutions position peaked at $6.7M in Q3 2018.
  • 272 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2019.

Based on Meritage Portfolio Management's 13F filing for Q1 2019, filed 25 Apr 2019.